Pharmaceutical R&D: Costs, Risks, and Rewards (1993)

Chapter: APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities

Previous Chapter: APPENDIX F: Summary of Methods Used to Analyze Trends in Postpatient Revenues
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 302
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 303
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 304
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 305
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 306
Suggested Citation: "APPENDIX G: Estimating the Cost of Producing and Selling New Chemical Entities." National Research Council. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. Washington, DC: The National Academies Press. doi: 10.17226/20876.
Page 307
Next Chapter: 'APPENDIX H: Methods of OTA's Survey of Clinical Trial Size'
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.